-
Press Room
-
Press Releases
-
Feb 12, 2021
2:30 PM
VolitionRx Limited Announces Closing of $20 Million Underwritten Public Offering of Common Stock
-
Feb 10, 2021
2:30 PM
VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
-
Feb 09, 2021
9:15 PM
VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock
-
Feb 02, 2021
1:00 PM
VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts
-
Jan 28, 2021
11:30 AM
National Taiwan University Hospital Presents Data on Nu.Q™ Assay Performance at the World Conference on Lung Cancer
-
Jan 25, 2021
2:00 PM
VolitionRx Limited Opens its New Manufacturing Facility in Belgium
-
Jan 06, 2021
1:30 PM
VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding